摘要
A method to enhance the limitation of synergistic chemodrugs based on nanomedicine delivering to tumors was proposed in a recent paper published in Nature Nanotechnology[1].This research not only improves current front-line combination therapies for multiple myeloma(MM),but also offers a novel design idea for nanomedicine of other diseases.
